Valiant Organics (VALIANTORG)

FairStock Score: 17/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹262.47, Valiant Organics is priced at only 1.12 times book value, with book value at ₹233.61. That sounds like a Graham-style bargain, but a low price is not a bargain when earnings have collapsed. Net profit is down 98.35 per cent, sales have fallen 14.77 per cent, and the latest quarter produced just ₹4 crore profit on ₹159 crore sales. That translates into very thin margins, a return on equity of only 3.55 per cent, and a ROCE of just 2.63 per cent. As Buffett says, it is wonderful if a great company has temporary problems, but this looks like a troubled business without a proven moat. The Piotroski F-score of 3 out of 9 confirms the financial stress. The only genuine comfort is the balance sheet: debt/equity is 0.32, so the company is not drowning in debt. The dividend yield is zero, meaning retained capital is earning very little. The P/E of 35.42 is not cheap in the ordinary sense; it is a distorted ratio after profits fell off a cliff. Promoter holding at 37.89 per cent is adequate, but not high enough to signal great owner alignment. I would need to see evidence that this is a temporary cyclical downturn, not permanent impairment. I want improving quarterly sales, expanding margins, and return ratios moving back toward double digits before I call this a turnaround. Price near book gives some downside cushion, but in specialty chemicals, a weak franchise can destroy book value too. Patience is better than buying a bargain that is not yet earning.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer